-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-measure-1-section-6-attachment-2.pdf
January 17, 2017 - Recommendation to include evaluation of sleep disorders (Neurology and Sleep
Medicine, P.C.
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-6-attach-2.pdf
February 02, 2017 - Recommendation to include evaluation of sleep disorders (Neurology and Sleep
Medicine, P.C.
-
www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-measure-1-section-6-attachment-2.pdf
January 17, 2017 - Recommendation to include evaluation of sleep disorders (Neurology and Sleep
Medicine, P.C.
-
www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-6-attach-2.pdf
February 02, 2017 - Recommendation to include evaluation of sleep disorders (Neurology and Sleep
Medicine, P.C.
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-6-attach-2.pdf
February 02, 2017 - Recommendation to include evaluation of sleep disorders (Neurology and Sleep
Medicine, P.C.
-
www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-6-attach-2.pdf
February 02, 2017 - Recommendation to include evaluation of sleep disorders (Neurology and Sleep
Medicine, P.C.
-
www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-measure-1-section-6-attachment-2.pdf
January 17, 2017 - Recommendation to include evaluation of sleep disorders (Neurology and Sleep
Medicine, P.C.
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-measure-1-section-6-attachment-2.pdf
January 17, 2017 - Recommendation to include evaluation of sleep disorders (Neurology and Sleep
Medicine, P.C.
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-measure-1-section-6-attachment-2.pdf
January 17, 2017 - Recommendation to include evaluation of sleep disorders (Neurology and Sleep
Medicine, P.C.
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-measure-1-section-6-attachment-2.pdf
January 17, 2017 - Recommendation to include evaluation of sleep disorders (Neurology and Sleep
Medicine, P.C.
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-6-attach-2.pdf
February 02, 2017 - Recommendation to include evaluation of sleep disorders (Neurology and Sleep
Medicine, P.C.
-
hcup-us.ahrq.gov/reports/methods/MS2023-01-NHQDRMethodsReport_508.pdf
November 21, 2023 - disorder not due to a sub or known physiol cond, unsp
'F444' Conversion disorder with motor symptom … disorder
'F10288' Alcohol dependence with other alcohol-induced disorder
'F1029' Alcohol dependence … disorder
'F10988' Alcohol use, unspecified with other alcohol-induced disorder
'F1099' Alcohol use … disorder
'F13188' Sedative, hypnotic or anxiolytic abuse w oth disorder
'F1319' Sedative, hypnotic … disorder
'F14988' Cocaine use, unspecified with other cocaine-induced disorder
'F1499' Cocaine use
-
srdr.ahrq.gov/projects/1565/studies/189171
January 01, 2005 - Select a Topic:
User Home Screen
Extraction Forms
Project Creation
Study Creation
Preview Pages
Other
Your Feedback:
Submit
Reset
Cancel
Study Preview
Study Title and Description
Long-term cardiovascular outcomes in men with obst…
-
hcup-us.ahrq.gov/reports/methods/MS2022-01-NHQDRMethodsReport.pdf
October 28, 2022 - disorder not due to a sub or known physiol cond, unsp
'F444' Conversion disorder with motor symptom … disorder
'F10288' Alcohol dependence with other alcohol-induced disorder
'F1029' Alcohol dependence … disorder
'F10988' Alcohol use, unspecified with other alcohol-induced disorder
'F1099' Alcohol use … disorder
'F13188' Sedative, hypnotic or anxiolytic abuse w oth disorder
'F1319' Sedative, hypnotic … disorder
'F14988' Cocaine use, unspecified with other cocaine-induced disorder
'F1499' Cocaine use
-
srdr.ahrq.gov/projects/1565/studies/188519
January 01, 2019 - Select a Topic:
User Home Screen
Extraction Forms
Project Creation
Study Creation
Preview Pages
Other
Your Feedback:
Submit
Reset
Cancel
Study Preview
Study Title and Description
Nonfatal and fatal cardiovascular disease events i…
-
hcup-us.ahrq.gov/reports/methods/2020-04.pdf
January 01, 2020 - disorder not due to a sub or known physiol cond, unsp
'F444' Conversion disorder with motor symptom … disorder
'F10288' Alcohol dependence with other alcohol-induced disorder
'F1029' Alcohol dependence … disorder
'F10988' Alcohol use, unspecified with other alcohol-induced disorder
'F1099' Alcohol use … disorder
'F13188' Sedative, hypnotic or anxiolytic abuse w oth disorder
'F1319' Sedative, hypnotic … disorder
'F14988' Cocaine use, unspecified with other cocaine-induced disorder
'F1499' Cocaine use
-
hcup-us.ahrq.gov/reports/methods/MS2021-03-NHQDRMethodsReport.pdf
December 09, 2021 - disorder not due to a sub or known physiol cond, unsp
'F444' Conversion disorder with motor symptom … disorder
'F10288' Alcohol dependence with other alcohol-induced disorder
'F1029' Alcohol dependence … disorder
'F10988' Alcohol use, unspecified with other alcohol-induced disorder
'F1099' Alcohol use … disorder
'F13188' Sedative, hypnotic or anxiolytic abuse w oth disorder
'F1319' Sedative, hypnotic … disorder
'F14988' Cocaine use, unspecified with other cocaine-induced disorder
'F1499' Cocaine use
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/pbt-lsr-draft-ets-obs.xlsx
March 15, 2022 - Table E-5. Can. Cohort Studies
Table E-5. Cannabis cohort studies
PMID Author, Year Study Design Setting Pain Population Pain Condition Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race, Hispanic/Latino % Race, Asian % Race, Other % Pain Duration Measure
(Mean, Median) Pain Duration, Mon…
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/Pain%20Management%20Summary%20Clincial%20Decision%20Support%20Toolkit_for%20Repository.xlsx
January 01, 2003 - for Oral Suspension 200194 zolmitriptan 5 MG Oral Tablet F10.182 Alcohol abuse with alcohol-induced sleep … disorder 198014 Naproxen 500 MG Oral Tablet 1870933 Naloxone Hydrochloride 20 MG/ML Nasal Spray … disorder 197806 Ibuprofen 600 MG Oral Tablet
313165 0.5 ML Sumatriptan 12 MG/ML Injection F11.188 … disorder 1192984 Benzocaine 4 MG/ML / Docusate Sodium 56.6 MG/ML Enema
F11.988 Opioid use, … disorder 1873757 plecanatide 3 MG Oral Tablet
F13.188 Sedative, hypnotic or anxiolytic abuse
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/obstructive-sleep-apnea-in-adults-screening
January 24, 2017 - Evidence Summary
Obstructive Sleep Apnea in Adults: Screening
January 24, 2017
Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services.
…